药理干预和新型治疗方法的进步用于肌缩侧面硬化症的治疗方法
María Montiel-Troya1, Himan Mohamed-Mohamed2, Teresa Pardo-Moreno1
1Faculty of Health Sciences Ceuta, University of Granada, 51001 Ceuta, Spain.
Biomedicines
|October 26, 2024
概括
肌缩侧面硬化症 (ALS) 的治疗包括像瑞卢和埃达拉这样的药物,以及用于症状管理和改善生活质量的疗法. 多学科的方法是管理这种渐进的神经退行性疾病的关键.
科学领域:
- 神经学 神经学
- 神经科学是一个神经科学.
- 医学研究 医学研究
背景情况:
- 肌缩侧面硬化 (ALS) 是一种进展性神经退行性疾病,影响运动神经元,导致和死亡.
- 性别是ALS发展的一个公认的风险因素.
- 目前的理解包括病理生理机制,但确定的治疗方法仍然难以捉摸.
研究的目的:
- 系统地审查氨缩侧面硬化症 (ALS) 的药理和非药理疗法.
- 突出对ALS患者进行综合,多学科治疗策略的必要性.
主要方法:
- 对有关ALS治疗的现有文献进行系统审查.
- 对基于药物和支持性护理干预措施的分析.
主要成果:
- 研究中的药物包括瑞卢,埃达拉和甲酸.
- 像masitinib这样的新兴治疗方法显示出有希望的结果.
- 非药物治疗包括心理支持,语言治疗和物理治疗.
结论:
- 虽然没有治愈方法,但各种疗法可以减缓ALS的进展并缓解症状.
- 综合药理和非药理方法的多学科护理对于提高患者生活质量至关重要.
更多相关视频
10:49Intraspinal Cell Transplantation for Targeting Cervical Ventral Horn in Amyotrophic Lateral Sclerosis and Traumatic Spinal Cord Injury
Published on: September 18, 2011
20.6K
10:57Intramuscular Injections Along the Motor End Plates: A Minimally Invasive Approach to Shuttle Tracers Directly into Motor Neurons
Published on: July 13, 2015
12.6K
相关概念视频
Alzheimer's Disease: Treatment
165
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
165
Parkinson's Disease: Overview
486
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
486
Drug Therapy
39
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
39
Parkinson's Disease: Treatment
227
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
227
Microorganisms in Medicine and Therapeutics
1
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1
Alzheimer's Disease: Overview
449
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
449
